Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel Sells 29,730 Shares

Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel sold 29,730 shares of the firm’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $174,515.10. Following the transaction, the chief executive officer owned 1,892,774 shares of the company’s stock, valued at approximately $11,110,583.38. This represents a 1.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Stock Performance

SRTA opened at $5.48 on Thursday. The stock has a market capitalization of $474.18 million, a price-to-earnings ratio of -68.50 and a beta of 2.20. The stock’s fifty day moving average price is $5.17. Strata Critical Medical has a 52 week low of $3.57 and a 52 week high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last released its earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.07. The firm had revenue of $67.38 million during the quarter. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%. Research analysts expect that Strata Critical Medical will post -0.14 earnings per share for the current year.

Institutional Trading of Strata Critical Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Bank of America Corp DE raised its stake in Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after buying an additional 25,379 shares in the last quarter. Quantinno Capital Management LP raised its stake in Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after buying an additional 71,155 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after buying an additional 172,154 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in Strata Critical Medical in the first quarter valued at $537,000. Finally, Granite Investment Partners LLC raised its stake in Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after buying an additional 7,911 shares in the last quarter. 47.36% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SRTA has been the subject of a number of recent research reports. Weiss Ratings upgraded Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. Zacks Research upgraded Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. B. Riley Financial initiated coverage on Strata Critical Medical in a report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 target price for the company. Finally, Craig Hallum initiated coverage on Strata Critical Medical in a report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.